Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1101091
Abstract: Adipose tissue malfunction leads to altered adipokine secretion which might consequently contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus, and cardiovascular disorders. Asprosin is a novel diabetogenic adipokine classified as a… read more here.
Keywords: asprosin health; adipose tissue; new glucose; adipokine ... See more keywords